Comparison of Dexmedetomidine and ketamin in children undergoing CT scan

Comparison of sedative effects of intramuscular Dexmedetomidine and intramuscular ketamin in children undergoing CT scan

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180602039940N1

Enrollment

Registered

2019-02-24

Start date

2019-03-06

Completion date

Unknown

Last updated

2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients referred for brain CT scan.

Interventions

Intervention 1: Intervention group:4 mg/kg Intramuscular Ketamine. Intervention 2: Intervention group: 3µg/kg Intramuscular Dexmedetomidine.

Eligibility

Sex/Gender

All

Age

2 Years to 8 Years

Inclusion criteria

Inclusion criteria: Children 2 to 8 years of age who have been referred for brain CT scan

Exclusion criteria

Exclusion criteria: Unanticipated difficult airway History of adverse reactions to the drugs used in the study Hemodynamic instability Respiratory diseases of the upper and lower airways Cardiovascular disease Patients are taking Digoxin and beta-blocker Liver and kidney disease

Design outcomes

Primary

Measure	Time frame
Sedation degree. Timepoint: 5, 10, 15, 25, 35, 45, 60 minutes after the intervention. Method of measurement: Ramsay criteria.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSamaneh Porozan

Ahvaz University of Medical Sciences

meberar@yahoo.com+98 61 3222 2922

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026